[Lymph- and haemangiosis carcinomatosa--an important prognostic factor in non-small-cell bronchial carcinoma (NSCLC)].
Between 1 Jan 1984-1 Jan 1990, 199 patients underwent curative (R0) surgery for non-small cell lung cancer. The pathohistological findings showed that a carcinomatous lymphangiosis and haemangiosis (L/H pos.) were present in 26 patients. In six patients, no lymph node metastases were detected. The median (22 mo. vs. 74 mo.) and 5-year survival (25% vs. 41%) were significantly (p < 0.001) higher compared to patients with and without lymphangiosis and haemangiosis carcinomatosa (L/H neg.). There were also significant (p < 0.05) differences in the survival time between pNO L/H neg. and pNO L/H pos. patients (median 74 mo. vs. 15 mo.-5 years 43% vs. 0%).
Schultheis
K H
KH
Klinik für Viszeral-, Thorax- und Endokrine Chirurgie, Städtisches Klinikum Nürnberg Nord.
Baumann
M
M
Meyer
W
W
Gebhardt
C
C
Mittelmeier
H O
HO
Wünsch
P
P
D002196:Capillaries / Q000473:pathology; D002283:Carcinoma, Bronchogenic / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008168:Lung / Q000098:blood supply; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D015996:Survival Rate
Lymph- und Haemangiosis carcinomatosa--ein wichtiger Prognosefaktor beim nicht-kleinzelligen Bronchialkarzinom (NSCLC).